What is the best treatment strategy for incidentally detected small renal masses? A decision analysis

BJU International

Volumn 108, Issue 8 B, 2011, Pages

  Abouassaly, Robert ^a   Yang, Simon ^b   Finelli, Antonio ^b   Kulkarni, Girish S ^b   Alibhai, Shabbir M H ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ablation techniques; decision analysis; decision making; kidney neoplasms; laparoscopy; nephrectomy

Indexed keywords

AGE; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC KIDNEY FAILURE; CRYOTHERAPY; DISEASE CONTROL; EXTERNAL VALIDITY; HAZARD RATIO; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; KIDNEY CANCER; KIDNEY FUNCTION; LAPAROSCOPIC SURGERY; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; NEPHRECTOMY; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; RADIOFREQUENCY ABLATION; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; TUMOR VOLUME; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; DECISION SUPPORT TECHNIQUES; HUMANS; INCIDENTAL FINDINGS; KIDNEY NEOPLASMS; MARKOV CHAINS; MIDDLE AGED; NEPHRECTOMY;

EID: 80051549507     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10115.x     Document Type: Article

References (63)

1. Nguyen CT, Campbell SC,. Staging of renal cell carcinoma: past, present, and future. Clin Genitourin Cancer 2006; 5: 190-7 (Pubitemid 46190380)
2. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr,. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628-31 (Pubitemid 29211773)
3. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR,. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113: 78-83 (Pubitemid 351976389)
4. Katz DL, Zheng T, Holford TR, Flannery J,. Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935-1989. Int J Cancer 1994; 58: 57-63 (Pubitemid 24213970)
5. Hafez KS, Fergany AF, Novick AC,. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162: 1930-3
6. Abouassaly R, Alibhai SM, Tomlinson G, Timilshina N, Finelli A,. Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J Urol 2010; 183: 467-72
7. Huang WC, Levey AS, Serio AM, et al,. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7: 735-40 (Pubitemid 44283660)
8. Thompson RH, Boorjian SA, Lohse CM, et al,. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179: 468-71
9. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P,. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes? J Urol 2009; 181: 61-2
10. Stein RJ, Kaouk JH,. Renal cryotherapy: a detailed review including a 5-year follow-up. BJU Int 2007; 99: 1265-70 (Pubitemid 46624165)
11. Lane BR, Abouassaly R, Gao T, et al,. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 2010; 116: 3119-26
12. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG,. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425-31 (Pubitemid 43067318)
13. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA,. The natural history of incidentally detected small renal masses. Cancer 2004; 100: 738-45 (Pubitemid 38176851)
14. Hsieh MH, Meng MV,. Decision analysis and Markov modeling in urology. J Urol 2007; 178: 1867-74 (Pubitemid 47538586)
15. Kunkle DA, Egleston BL, Uzzo RG,. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008; 179: 1227-33
16. Lesage K, Joniau S, Fransis K, Van Poppel H,. Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol 2007; 51: 614-20 (Pubitemid 46097283)
17. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305
18. Matin SF, Ahrar K, Cadeddu JA, et al,. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 2006; 176: 1973-7 (Pubitemid 44633171)
19. Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG,. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 2008; 112: 1051-7 (Pubitemid 351304589)
20. Duchene DA, Lotan Y, Cadeddu JA, Sagalowsky AI, Koeneman KS,. Histopathology of surgically managed renal tumors: analysis of a contemporary series. Urology 2003; 62: 827-30 (Pubitemid 37421225)
21. Shannon BA, Cohen RJ, de Bruto H, Davies RJ,. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 2008; 180: 1257-61
22. Schachter LR, Cookson MS, Chang SS, et al,. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol 2007; 21: 819-23 (Pubitemid 47443652)
23. Gillett MD, Cheville JC, Karnes RJ, et al,. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol 2005; 173: 1893-6 (Pubitemid 40675205)
24. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK,. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-4 (Pubitemid 44530728)
25. Lane BR, Gill IS,. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol 2010; 183: 473-9
26. Nguyen CT, Lane BR, Kaouk JH, et al,. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J Urol 2008; 180: 104-9
27. Motzer RJ, Hutson TE, Tomczak P, et al,. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115-24 (Pubitemid 46089672)
28. Escudier B, Eisen T, Stadler WM, et al,. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125-34 (Pubitemid 46089673)
29. Statistics Canada. Life tables, Canada, provinces and territories 2000-2002. Available at:. Accessed May 2010
30. Motzer RJ, Hutson TE, Tomczak P, et al,. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009; 27: 3584-90
31. Berber E, Siperstein AE,. Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases. Surg Endosc 2007; 21: 613-18 (Pubitemid 46439380)
32. Abouassaly R, Alibhai S, Timilshina N, Finelli A,. The morbidity of renal surgery: data from a population-based tumor registry. Abstract presented at AUA Annual Meeting, 2009
33. Corman JM, Penson DF, Hur K, et al,. Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program. BJU Int 2000; 86: 782-9
34. Cloutier V, Capitanio U, Zini L, et al,. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur Urol 2009; 56: 998-1005
35. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV,. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75-9
36. Mattar K, Basiuk J, Rendon R, et al,. Active surveillance of small renal masses: a prospective multi-center Canadian trial. Abstract presented at AUA Annual Meeting, 2009
37. Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S,. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 2007; 110: 1010-14 (Pubitemid 47312866)
38. Goel RK, Kaouk JH,. Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation. Curr Opin Urol 2008; 18: 467-73
39. Johnson DB, Solomon SB, Su LM, et al,. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 2004; 172: 874-7 (Pubitemid 39096411)
40. Campbell SC, Novick AC, Streem SB, Klein E, Licht M,. Complications of nephron sparing surgery for renal tumors. J Urol 1994; 151: 1177-80 (Pubitemid 24121911)
41. Stephenson AJ, Hakimi AA, Snyder ME, Russo P,. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol 2004; 171: 130-4 (Pubitemid 37549107)
42. Van Poppel H, Da Pozzo L, Albrecht W, et al,. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007; 51: 1606-15 (Pubitemid 46634740)
43. Porpiglia F, Volpe A, Billia M, Scarpa RM,. Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur Urol 2008; 53: 732-42
44. Pareek G, Hedican SP, Gee JR, Bruskewitz RC, Nakada SY,. Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques. J Urol 2006; 175: 1208-13
45. Permpongkosol S, Link RE, Su LM, et al,. Complications of 2,775 urological laparoscopic procedures: 1993 to 2005. J Urol 2007; 177: 580-5 (Pubitemid 46054038)
46. Dunn MD, Portis AJ, Shalhav AL, et al,. Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol 2000; 164: 1153-9
47. Borin JF,. Laparoscopic radical nephrectomy: long-term outcomes. Curr Opin Urol 2008; 18: 139-44 (Pubitemid 351317380)
48. Brunaud L, Kebebew E, Sebag F, Zarnegar R, Clark OH, Duh QY,. Observation or laparoscopic adrenalectomy for adrenal incidentaloma? A surgical decision analysis. Med Sci Monit 2006; 12: R355-62
49. Tengs TO, Wallace A,. One thousand health-related quality-of-life estimates. Med Care 2000; 38: 583-637
50. Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD,. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003; 21: 3318-27 (Pubitemid 46606266)
51. Pace KT, Dyer SJ, Phan V, et al,. Laparoscopic versus open donor nephrectomy. Surg Endosc 2003; 17: 134-42 (Pubitemid 41512079)
52. Cost effectiveness analysis registry. Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center. Available at:. Accessed May 2010
53. Cella DF, Tulsky DS, Gray G, et al,. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-9 (Pubitemid 23071057)
54. Miller DC, Saigal CS, Banerjee M, Hanley J, Litwin MS, Diseases U,. in America Project. Diffusion of surgical innovation among patients with kidney cancer. Cancer 2008; 112: 1708-17 (Pubitemid 351536830)
55. Briggs A,. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health 2005; 8: 1-2 (Pubitemid 40293635)
56. Fergany AF, Hafez KS, Novick AC,. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000; 163: 442-5 (Pubitemid 30060489)
57. Berger A, Brandina R, Atalla MA, et al,. Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more. J Urol 2009; 182: 2172-6
58. Abouassaly R, Lane BR, Novick AC,. Active surveillance of renal masses in elderly patients. J Urol 2008; 180: 505-8
59. Rifkin DE, Shlipak MG, Katz RDP, et al,. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008; 168: 2212-18
60. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006; 145: 237-46 (Pubitemid 46768607)
61. Sarnak MJ, Katz R, Fried LF, et al,. Cystatin C and aging success. Arch Intern Med 2008; 168: 147-53 (Pubitemid 351192910)
62. Campbell SC, Novick AC, Belldegrun A, et al,. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271-9
63. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT,. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 2006; 67: 254-9 (Pubitemid 43189837)